Aurobindo Pharma: Aurobindo Pharma arm gets U.S. FDA nod for generic of BMS' cancer drug
Aurobindo Pharma's Eugia Pharma has been approved the U.S. FDA to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel
Read full article »
Managing Director
K.Nithyananda Reddy
Aurobindo is an India-based multinational pharmaceutical firm that develops and manufactures active pharmaceutical ingredients and specialty drugs for the healthcare sector.
Read more